Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ayahuasca: Pharmacology, neuroscience and therapeutic potential.
Domínguez-Clavé E, Soler J, Elices M, Pascual JC, Álvarez E, de la Fuente Revenga M, Friedlander P, Feilding A, Riba J. Domínguez-Clavé E, et al. Among authors: feilding a. Brain Res Bull. 2016 Sep;126(Pt 1):89-101. doi: 10.1016/j.brainresbull.2016.03.002. Epub 2016 Mar 11. Brain Res Bull. 2016. PMID: 26976063 Review.
LSD and language: Decreased structural connectivity, increased semantic similarity, changed vocabulary in healthy individuals.
Wießner I, Falchi M, Daldegan-Bueno D, Palhano-Fontes F, Olivieri R, Feilding A, B Araujo D, Ribeiro S, Bezerra Mota N, Tófoli LF. Wießner I, et al. Among authors: feilding a. Eur Neuropsychopharmacol. 2023 Mar;68:89-104. doi: 10.1016/j.euroneuro.2022.12.013. Epub 2023 Jan 19. Eur Neuropsychopharmacol. 2023. PMID: 36669231 Clinical Trial.
Inhibition of alpha oscillations through serotonin-2A receptor activation underlies the visual effects of ayahuasca in humans.
Valle M, Maqueda AE, Rabella M, Rodríguez-Pujadas A, Antonijoan RM, Romero S, Alonso JF, Mañanas MÀ, Barker S, Friedlander P, Feilding A, Riba J. Valle M, et al. Among authors: feilding a. Eur Neuropsychopharmacol. 2016 Jul;26(7):1161-75. doi: 10.1016/j.euroneuro.2016.03.012. Epub 2016 Mar 25. Eur Neuropsychopharmacol. 2016. PMID: 27039035 Clinical Trial.
Assessing the Psychedelic "After-Glow" in Ayahuasca Users: Post-Acute Neurometabolic and Functional Connectivity Changes Are Associated with Enhanced Mindfulness Capacities.
Sampedro F, de la Fuente Revenga M, Valle M, Roberto N, Domínguez-Clavé E, Elices M, Luna LE, Crippa JAS, Hallak JEC, de Araujo DB, Friedlander P, Barker SA, Álvarez E, Soler J, Pascual JC, Feilding A, Riba J. Sampedro F, et al. Among authors: feilding a. Int J Neuropsychopharmacol. 2017 Sep 1;20(9):698-711. doi: 10.1093/ijnp/pyx036. Int J Neuropsychopharmacol. 2017. PMID: 28525587 Free PMC article.
Therapeutic potential of ayahuasca in grief: a prospective, observational study.
González D, Cantillo J, Pérez I, Farré M, Feilding A, Obiols JE, Bouso JC. González D, et al. Among authors: feilding a. Psychopharmacology (Berl). 2020 Apr;237(4):1171-1182. doi: 10.1007/s00213-019-05446-2. Epub 2020 Jan 14. Psychopharmacology (Berl). 2020. PMID: 31938878 Free PMC article. Clinical Trial.
64 results